OVERVIEW
Heart failure (HF) is a major cause of morbidity and mortality in the United States, with a prevalence that is expected to increase from about 6 million today to more than 8 million by 2030. A growing body of evidence pinpoints iron deficiency (ID) as an important comorbidity of HF, affecting more than 50% of patients with stable HF. Although the correction of ID is critical to improve outcomes in patients with HF, clinicians often overlook ID when providing HF care. Join our panel of experts for an engaging educational symposium to learn about the impact of ID on patients with HF, and leave with a greater awareness of current guidelines and best practices to diagnose and treat ID in patients with HF, including the role of intravenous iron in these patients based on clinical trial data.
GOAL STATEMENT
The goal of this activity is for learners to be better able to recognize and apply the most up-to-date evidence- based recommendations to identify, diagnose, and manage iron deficiency (ID) in patients with HF.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the[LIST][ITEM]Pathophysiology of ID in HF[ITEM]Impact of ID in patients with concomitant HF[ITEM]Latest clinical safety and efficacy data for the use of intravenous (IV) iron to treat ID in HF[/LIST]Have greater competence related to[LIST][ITEM]Application of guidance-based screening strategies to optimize the early diagnosis of ID in patients with HF[ITEM]Selection of evidence-based treatment strategies in patients with comorbid ID and HF, including the administration of IV iron based on current evidence and guideline recommendations[/LIST]Demonstrate greater confidence in their ability to [LIST][ITEM]Recognize and manage ID in patients with chronic HF[/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.25 [italic][bold]AMA PRA Category 1 Credits[/bold][/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Huntington Convention Center
Room 5
300 Lakeside Ave E
Cleveland, Ohio, 44113
United States
This Satellite Session is not part of the scientific program as planned by the HFSA Program Committee. The program topic, learning objectives, and faculty have been reviewed and approved by the ASM Program Review Committee for a satellite program at ASM 2023.
Supported by an independent educational grant from [bold]American Regent[/bold].
Organized by
